Nationality
American
Year of Birth
1966
Massachusetts Institute of Technology, M.Sc. in Management; M.Sc.in Chemical Engineering
University of Texas, Austin, B. S. in Chemical Engineering
1989
Process Engineer, R&D, Ethyl Corporation, The Hague, Netherlands
1990
Engineer/Shift Supervisor, Ethyl Corporation, Brussels, Belgium
1995
Business Development/Marketing Manager, Raychem Corporation, SF Bay Area, USA
1997
Business Planning Manager, Biogen, Cambridge, Massachusetts, USA
1999
Managing Director, United Kingdom and Ireland, Biogen, London, UK
2001
Vice President of Finance, Business Planning, Biogen Idec., Cambridge, Massachusetts, USA
2004
Vice President and General Manager, Neurology Business Unit, Biogen Idec., USA
2006
Senior Vice President, Immunology and Ophthalmology Business Unit, Genentech, USA
2010
Senior Vice President, BioOncology Business Unit, Genentech, USA
2013
Global Product Strategy Head/Chief Marketing Officer, Roche Pharmaceuticals, Basel, Switzerland
2016
Head of North American Operations, Genentech, USA
2017-2018
Chief Executive Officer, Genentech, USA
2019-present
CEO Roche Pharmaceutical
2019-present
Chugai Pharmaceuticals
FHI (Flatiron Health, Inc.)
FMI (Foundation Medicine, Inc.)
GNE (Genentech, Inc.)
Spark Therapeutics
2017-2018
BIO (Biotechnology Innovation Organization)
2019-2020
PhRMA (Pharmaceutical Research and Manufacturers of America)
Jan 2021-present
European Federation of Pharmaceuticals Industries and Associations
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.